{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:38:32Z","timestamp":1792669112788,"version":"4.5.0"},"reference-count":28,"publisher":"MyJove Corporation","issue":"138","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/55724","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T20:00:18Z","timestamp":1533931218000},"source":"Crossref","is-referenced-by-count":6,"title":["Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents"],"prefix":"10.3791","author":[{"given":"Naemeh","family":"Pourshafie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-lian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Harmison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Bott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Fischbeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Rinaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/gt.2011.50","type":"journal-article","article-title":"miRNA therapeutics","volume":"18","author":"Broderick","year":"2011","unstructured":"Broderick, J.A., Zamore, P.D. miRNA therapeutics. Gene Therapy. 18, 1104-1110 (2011).","journal-title":"Gene Therapy"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","type":"journal-article","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","unstructured":"Esteller, M. Non-coding RNAs in human disease. Nat Rev Genet. 12, 861-874 (2011).","journal-title":"Nat Rev Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcdb.2004.11.006","type":"journal-article","article-title":"The implications of structured 5' untranslated regions on translation and disease","volume":"16","author":"Pickering","year":"2005","unstructured":"Pickering, B.M., Willis, A.E. The implications of structured 5' untranslated regions on translation and disease. Semin Cell Dev Biol. 16, 39-47 (2005).","journal-title":"Semin Cell Dev Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2006.07.030","type":"journal-article","article-title":"MicroRNA pathways modulate polyglutamine-induced neurodegeneration","volume":"24","author":"Bilen","year":"2006","unstructured":"Bilen, J., Liu, N., Burnett, B.G., Pittman, R.N., Bonini, N.M. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell. 24, 157-163 (2006).","journal-title":"Mol Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nn.2183","type":"journal-article","article-title":"miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis","volume":"11","author":"Lee","year":"2008","unstructured":"Lee, Y., Samaco, R.C., Gatchel, J.R., Thaller, C., Orr. H.T., Zoghbi, H.Y. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci. 11, 1137-1139 (2008).","journal-title":"Nat Neurosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10810","type":"journal-article","article-title":"The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila","volume":"482","author":"Liu","year":"2012","unstructured":"Liu, N., et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature. 482, 519-523 (2012).","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2174\/1381612820666140929095755","type":"journal-article","article-title":"Strategies for skeletal muscle targeting in drug discovery","volume":"10","author":"Ebner","year":"2015","unstructured":"Ebner, D.C., et al. Strategies for skeletal muscle targeting in drug discovery. Curr Pharm Des. 10,1327-1336 (2015).","journal-title":"Curr Pharm Des"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s00018-016-2275-1","type":"journal-article","article-title":"Polyglutamine androgen receptor-mediated neuromuscular disease","volume":"73","author":"Giorgetti","year":"2016","unstructured":"Giorgetti, E., Lieberman, AP. Polyglutamine androgen receptor-mediated neuromuscular disease. Cell Mol Life Sci. 73, 3991-3999 (2016).","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/odi.12121","type":"journal-article","article-title":"Spinal and bulbar muscular atrophy: pathogenesis and clinical management","volume":"20","author":"Grunseich","year":"2014","unstructured":"Grunseich, C., Rinaldi, C., Fischbeck, K.H. Spinal and bulbar muscular atrophy: pathogenesis and clinical management. Oral Dis. 20, 6-9 (2014).","journal-title":"Oral Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","type":"journal-article","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","unstructured":"La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E., Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 352, 77-79 (1991).","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","type":"journal-article","article-title":"Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"35","author":"Katsuno","year":"2002","unstructured":"Katsuno, M., Adachi, H., Kume, A., Li, M., Nakagomi, Y., Niwa, H., Sang, C., Kobayashi, Y., Doyu, M., Sobue, G. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 35, 843-854 (2002).","journal-title":"Neuron"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1074\/jbc.M807530200","type":"journal-article","article-title":"MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1","volume":"284","author":"Boissonneault","year":"2009","unstructured":"Boissonneault, V., Plante, I., Rivest, S., Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem., 284, 1971-1981 (2009).","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/mt.2015.231","type":"journal-article","article-title":"Widespread central nervous system gene transfer and silencing after systemic delivery of novel AAV-AS vector","volume":"24","author":"Choudhury","year":"2016","unstructured":"Choudhury, S.R., et al. Widespread central nervous system gene transfer and silencing after systemic delivery of novel AAV-AS vector. Mol Ther. 24, 726-735 (2016).","journal-title":"Mol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/mt.2016.13","type":"journal-article","article-title":"MiR-298 counteracts mutant androgen receptor toxicity in spinal and bulbar muscular atrophy","volume":"24","author":"Pourshafie","year":"2016","unstructured":"Pourshafie, N., et al. MiR-298 counteracts mutant androgen receptor toxicity in spinal and bulbar muscular atrophy. Mol Ther. 24, 937-45 (2016).","journal-title":"Mol Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","type":"journal-article","article-title":"miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes","volume":"44","author":"Dweep","year":"2011","unstructured":"Dweep, H., Sticht, C., Pandey, P., Gretz, N. miRWalk--database: prediction of possible miRNA binding sites by \"walking\" the genes of three genomes. J Biomed Inform. 44, 839-847 (2011).","journal-title":"J Biomed Inform"},{"issue":"57","key":"ref16","first-page":"e3348","type":"journal-article","article-title":"Production and titering of recombinant adeno-associated viral vectors","author":"McClure","year":"2011","unstructured":"McClure, C., Cole, K.L., Wulff, P., Klugmann, M., Murray, A.J. Production and titering of recombinant adeno-associated viral vectors. J Vis Exp. (57) e3348. (2011).","journal-title":"J Vis Exp"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0165-0270(95)00017-O","type":"journal-article","article-title":"Embedding, sectioning, immunocytochemical and stereological methods that optimise research on the lesioned adult rat spinal cord","volume":"61","author":"Stuard","year":"1995","unstructured":"Stuard, D.A., Oorschot, D.E. Embedding, sectioning, immunocytochemical and stereological methods that optimise research on the lesioned adult rat spinal cord. J Neurosci Methods. 61, 5-14 (1995).","journal-title":"J Neurosci Methods"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1016\/j.febslet.2014.11.013","type":"journal-article","article-title":"miR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3","volume":"588","author":"Huang","year":"2014","unstructured":"Huang, F., et al. miR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3. FEBS Lett. 588 4791-4798 (2014).","journal-title":"FEBS Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ymeth.2007.09.005","type":"journal-article","article-title":"Experimental validation of miRNA targets","volume":"44","author":"Kuhn","year":"2008","unstructured":"Kuhn, D.E., Martin, M.M., Feldman, D.S., Terry, A.V., Nuovo, G.J., Elton, T.S. Experimental validation of miRNA targets. Methods. 44, 47-54 (2008).","journal-title":"Methods"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/2230-973X.167646","type":"journal-article","article-title":"An overview of viral and nonviral delivery systems for microRNA","volume":"5","author":"Yang","year":"2015","unstructured":"Yang, N., An overview of viral and non-viral delivery systems for microRNA. Int J Pharm Investig. 5, 179-181 (2015).","journal-title":"Int J Pharm Investig"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fnmol.2014.00050","type":"journal-article","article-title":"Systemic gene delivery to the central nervous system using Adeno-associated virus","volume":"7","author":"Bourdenx","year":"2014","unstructured":"Bourdenx, M., Dutheil, N., Bezard, E. and Dehay, B. Systemic gene delivery to the central nervous system using Adeno-associated virus. Front Mol Neurosci. 7 50 (2014).","journal-title":"Front Mol Neurosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","type":"journal-article","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","unstructured":"Foust, K.D., Nurre, E., Montgomery, C.L., Hernandez, A., Chan, C.M. and Kaspar, B.K. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol. 27, 59-65 (2009).","journal-title":"Nat Biotechnol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/sj.gt.3302133","type":"journal-article","article-title":"Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo","volume":"10","author":"Wang","year":"2003","unstructured":"Wang, Z., Ma, H-I., Li, J., Sun, L., Zhang, J. and Xiao, X. Rapid and highly efficient transduction by double-standard adeno-associated virus vectors in vitro and in vivo. Gene Therapy. 10, 2105-2111 (2003).","journal-title":"Gene Therapy"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nbt0909-804","type":"journal-article","article-title":"The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9","volume":"27","author":"Saunders","year":"2009","unstructured":"Saunders, N.R., Joakim Ek, C. and Dziegielewska, K.M. The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9. Nat Biotechnol. 27, 804-805 (2009).","journal-title":"Nat Biotechnol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/mt.2011.185","type":"journal-article","article-title":"Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington\u2019s disease","volume":"19","author":"Boudreau","year":"2011","unstructured":"Boudreau, R.L., Spengler, R.M. and Davidson, B.L. Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington\u2019s disease. Mol Ther. 19, 2169\u20132177 (2011).","journal-title":"Mol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","type":"journal-article","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","unstructured":"Duque, S., Joussemet, B., Riviere, C., Marais, T., Dubreil, L., Douar, A.M. et al. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol Ther. 17, 1187-1196 (2009).","journal-title":"Mol Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nbt0109-42","type":"journal-article","article-title":"Crossing the rubicon","volume":"27","author":"Lowenstein","year":"2009","unstructured":"Lowenstein, P.R. Crossing the rubicon. Nat Biotechnol. 27, 42-44 (2009).","journal-title":"Nat Biotechnol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9863","DOI":"10.1093\/nar\/gks712","type":"journal-article","article-title":"Silencing of Parkinson's disease-associated genes with artificial mirtron mimics of miR-1224","volume":"40","author":"Sibley","year":"2012","unstructured":"Sibley, C.R., Seow, Y., Curtis, H., Weinberg, M.S. and Wood, M.J. Silencing of Parkinson's disease-associated genes with artificial mirtron mimics of miR-1224. Nucleic Acids Res. 40, 9863-9875 (2012).","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/video\/55724\/systemic-delivery-microrna-using-recombinant-adeno-associated-virus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:42:30Z","timestamp":1792665750000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/55724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":28,"journal-issue":{"issue":"138","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3791\/55724","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]}}}